wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51615048-F73EC810-0D7A-4B84-81C4-8B934AC7B630
Q51615048-F73EC810-0D7A-4B84-81C4-8B934AC7B630
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51615048-F73EC810-0D7A-4B84-81C4-8B934AC7B630
Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.
P2860
Q51615048-F73EC810-0D7A-4B84-81C4-8B934AC7B630
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51615048-F73EC810-0D7A-4B84-81C4-8B934AC7B630
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
95f1321f24a5c6089405df184142c898798cc0c6
P2860
Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid Leukemia.